Article thumbnail

Analysis of Behavior and Trafficking of Dendritic Cells within the Brain during Toxoplasmic Encephalitis

By Beena John, Brendon Ricart, Elia D. Tait Wojno, Tajie H. Harris, Louise M. Randall, David A. Christian, Beth Gregg, Daniel Manzoni De Almeida, Wolfgang Weninger, Daniel A. Hammer and Christopher A. Hunter


Under normal conditions the immune system has limited access to the brain; however, during toxoplasmic encephalitis (TE), large numbers of T cells and APCs accumulate within this site. A combination of real time imaging, transgenic reporter mice, and recombinant parasites allowed a comprehensive analysis of CD11c+ cells during TE. These studies reveal that the CNS CD11c+ cells consist of a mixture of microglia and dendritic cells (DCs) with distinct behavior associated with their ability to interact with parasites or effector T cells. The CNS DCs upregulated several chemokine receptors during TE, but none of these individual receptors tested was required for migration of DCs into the brain. However, this process was pertussis toxin sensitive and dependent on the integrin LFA-1, suggesting that the synergistic effect of signaling through multiple chemokine receptors, possibly leading to changes in the affinity of LFA-1, is involved in the recruitment/retention of DCs to the CNS and thus provides new insights into how the immune system accesses this unique site

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2005). A
  2. (2005). Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells.
  3. (2010). Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the bloodbrain barrier during experimental autoimmune encephalomyelitis.
  4. (2007). Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
  5. (2009). Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesisassociated system of reticular fibers.
  6. (2005). Blood-derived dendritic cells in an acute brain injury.
  7. (2001). Brain dendritic cells and macrophages/ microglia in central nervous system inflammation.
  8. (1996). Cells and cytokines in resistance to Toxoplasma gondii.
  9. (2002). Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma.
  10. (2001). Chemokines stimulate human T lymphocyte transendothelial migration to utilize VLA-4 in addition to LFA-1.
  11. (2000). Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow.
  12. (2006). CNS dendritic cells: critical participants in CNS inflammation? Neurochem Int 49: 195–203. Behavior and Function of DCs
  13. (2007). CNS myeloid DCs presenting endogenous myelin peptides ‘preferentially’ polarize CD4+ T(H)-17 cells in relapsing EAE.
  14. (2011). Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors.
  15. (2007). Cutting edge: CNS CD11c+ cells from mice with encephalomyelitis polarize Th17 cells and support CD25+CD4+ T cell-mediated immunosuppression, suggesting dual roles in the disease process.
  16. (2006). Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice.
  17. (2008). Dendritic cell behaviour in vivo: lessons learned from intravital two-photon microscopy.
  18. (2007). Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP1alpha chemokine and matrix metalloproteinases.
  19. (2006). Dendritic cells amplify T cell-mediated immune responses in the central nervous system.
  20. (2005). Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.
  21. (2001). Developmental plasticity of CNS microglia.
  22. (2008). Dissemination of extracellular and intracellular Toxoplasma gondii tachyzoites in the blood flow.
  23. (1997). Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligand-treated mice.
  24. (2009). Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii.
  25. (2009). Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node.
  26. (2002). Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.
  27. (2004). Expression of CCR7 in multiple sclerosis: implications for CNS immunity.
  28. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages.
  29. (2004). Hematopoietic origin of microglial and perivascular cells in brain.
  30. (2010). Host Cell Preference of Toxoplasma gondii Cysts in Murine Brain: A Confocal Study.
  31. (2002). Host resistance in the brain against Toxoplasma gondii.
  32. (2010). Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells.
  33. (2002). Immunopathogenesis of cerebral toxoplasmosis.
  34. (2004). Initiation of immune responses in brain is promoted by local dendritic cells.
  35. (2009). Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS.
  36. (2008). Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection.
  37. (2001). Ling EA
  38. (2008). Lymphocytic choriomeningitis infection of the central nervous system.
  39. (2007). Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers.
  40. (2005). Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
  41. (2007). Microglial recruitment, activation, and proliferation in response to primary demyelination.
  42. (2006). Molecular mechanisms involved in T cell migration across the blood-brain barrier.
  43. (2006). Natalizumab and progressive multifocal leucoencephalopathy.
  44. (2008). Natalizumab: targeting alpha4-integrins in multiple sclerosis.
  45. (2004). Neutrophils, dendritic cells and Toxoplasma.
  46. (2000). Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii.
  47. (1992). Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.
  48. (1998). Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.
  49. (2005). Regulation of immune cell adhesion and migration by regulator of adhesion and cell polarization enriched in lymphoid tissues.
  50. (2010). Removal of Toxoplasma gondii Cysts from the Brain by Perforin-Mediated Activity of CD8+ T Cells.
  51. (1992). Sher A
  52. (2008). Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
  53. (2007). Tatfunctionalized near-infrared emissive polymersomes for dendritic cell labeling.
  54. (2009). Therapy: Targeted but not trouble-free: efalizumab and PML.
  55. (2010). Tolerogenic dendritic cells in the control of autoimmune neuroinflammation: an emerging role of protein-glycan interactions.
  56. (2009). Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.
  57. (2010). Trafficking of immune cells in the central nervous system.
  58. (2010). Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells.
  59. (2004). Visualizing dendritic cell networks in vivo.